The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Scopus BioPharma Inc(NASDAQ:SCPS)


Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives...
Website: https://scopusbiopharma.com/
Founded: 2017
Full Time Employees: 1 (May 2021)
CEO: Joshua R. Lamstein
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Scopus BioPharma Op Cashflow Per Share ttm
Scopus BioPharma Free Cashflow Per Share ttm
Scopus BioPharma Cash Per Share ttm
Scopus BioPharma (GAAP) P/E ratio ttm
Scopus BioPharma P/B ratio ttm
No extra charts and metrics for this ticker.